MZT1

MZT1 (MOZART1) is a small, conserved component of the γ-tubulin ring complex (γ-TuRC) that functions as a critical assembly factor and MTOC-targeting adaptor for microtubule nucleation. MZT1 directly binds the N-terminal domains of multiple GCP subunits—particularly GCP3—via a promiscuous intercalative binding mode revealed by crystal structures, stabilizing GCP3 in an interaction-competent conformation required for assembly of the functional ring-shaped γ-TuRC and potent microtubule nucleation (PMID:31287970, PMID:32610137). MZT1–GCP3 subcomplexes anchor NEDD1 to GCP4/5/6 within the γ-TuRC lumen, bridging the nucleation complex to MTOC-tethering factors and controlling cell-cycle-dependent subcellular localization of γ-TuRC (PMID:23885124, PMID:32610137). MZT1 also stabilizes NEDD1 by inhibiting its ubiquitination, and its loss in gastric cancer cells impairs proliferation, migration, and glycolysis (PMID:40204068).

1. 2013 High

   The first question was whether this uncharacterized small protein had any role in microtubule organization; fission yeast studies established that Mzt1 is essential for γ-tubulin complex recruitment to MTOCs but dispensable for core γ-TuC assembly, placing it as a targeting factor rather than a structural subunit.

   Evidence Temperature-sensitive mutant analysis, co-immunoprecipitation, and fluorescence microscopy in fission yeast

   PMID:23885124

   Open questions at the time

   • Mechanism of MTOC recruitment unknown
   • Whether Mzt1 contacts γ-TuC subunits directly was unresolved
2. 2013 High

   Identification of the direct binding partner resolved how Mzt1 interfaces with the γ-tubulin complex: it binds the N-terminal region of GCP3 (Alp6), establishing the Mzt1–GCP3 interaction as the primary physical link.

   Evidence Yeast two-hybrid, co-immunoprecipitation, and biophysical assays with recombinant fission yeast proteins

   PMID:24006493

   Open questions at the time

   • Structural basis of interaction unknown
   • Whether binding extends to other GCP family members untested
   • Cytokinesis defects observed but mechanism unclear
3. 2017 High

   Extending the findings to human MZT1, NMR revealed its three alpha-helical regions and confirmed direct interaction with the GCP3 N-terminus, establishing structural conservation of the MZT1–GCP3 axis across eukaryotes.

   Evidence NMR spectroscopy, SEC-MALS, and dynamic light scattering on recombinant human MZT1 and GCP3 fragments

   PMID:28851027

   Open questions at the time

   • Atomic-resolution complex structure lacking
   • Functional consequence of oligomerization in solution unknown
4. 2018 High

   Drosophila studies revealed that Mzt1 generates MTOC-specific γ-TuRC heterogeneity: it is present in basal-body-associated but not mitochondrial γ-TuRCs in sperm, and its loss disrupts basal body positioning and sperm motility, demonstrating tissue-specific and context-dependent roles.

   Evidence Drosophila mzt1 mutant analysis with fluorescence microscopy and γ-TuRC composition profiling

   PMID:29983314

   Open questions at the time

   • How Mzt1 confers MTOC selectivity at the molecular level unknown
   • Mammalian tissue-specific roles unexplored
5. 2019 High

   In vitro reconstitution answered the mechanistic question of why Mzt1 is needed: it stabilizes GCP3 in an interaction-competent conformation within γ-TuSC, enabling assembly of a ring-shaped holocomplex with potent microtubule nucleation activity.

   Evidence In vitro reconstitution of microtubule nucleation from purified recombinant fission yeast γ-TuSC components with sedimentation analysis

   PMID:31287970

   Open questions at the time

   • Structural basis of GCP3 stabilization not visualized
   • Whether this mechanism applies identically in human γ-TuRC untested
6. 2020 High

   Crystal structures resolved the binding mode: Mzt1 intercalates into N-terminal domains of multiple GCP subunits promiscuously, and this promiscuity controls cell-cycle-dependent subcellular localization and microtubule nucleation/stabilization specificity.

   Evidence X-ray crystallography of Mzt1–GCP complexes, genetic and fluorescence microscopy analysis in fission yeast

   PMID:32610137

   Open questions at the time

   • How promiscuous binding is regulated to achieve specificity at different MTOCs unresolved
   • Whether post-translational modifications modulate binding preference unknown
7. 2024 High

   Cryo-EM of human γ-TuRC revealed the architectural role of MZT1: MZT1–GCP3 subcomplexes reside in the cone lumen and anchor NEDD1's C-terminus to GCP4/5/6, explaining how γ-TuRC is tethered to MTOCs via NEDD1.

   Evidence Cryo-EM structure determination with AlphaFold modeling and biochemical pulldown validation (preprint)

   Open questions at the time

   • Preprint awaiting peer review
   • Stoichiometry of MZT1 copies per γ-TuRC not fully settled
   • Dynamic regulation of MZT1–NEDD1 interaction in vivo unknown
8. 2025 Medium

   Beyond structural roles, MZT1 was found to regulate NEDD1 protein stability by inhibiting its ubiquitination, linking MZT1 to oncogenic signaling: MZT1 loss in gastric cancer cells reduces NEDD1 levels and impairs proliferation, migration, and glycolysis.

   Evidence Ubiquitination assays, proteomics, knockdown experiments in gastric cancer cell lines and xenograft models

   PMID:40204068

   Open questions at the time

   • E3 ligase whose activity MZT1 counteracts not identified
   • Whether NEDD1 stabilization is the sole pathway mediating oncogenic effects unclear
   • Single-lab finding

• Key open questions include: what E3 ubiquitin ligase targets NEDD1 and how MZT1 blocks it; how post-translational modifications regulate MZT1's promiscuous GCP binding to achieve MTOC selectivity; and the in vivo stoichiometry and dynamics of MZT1 within assembled human γ-TuRC.
• No E3 ligase identified for MZT1-regulated NEDD1 ubiquitination
• No in vivo structural dynamics data
• Tissue-specific roles in mammals not characterized